Clostridium difficile toxin a inhibits the kinase activity of extracellular signal-related kinases 1 and 2 through direct binding

Journal of Microbiology and Biotechnology

Volumn 22, Issue 2, 2012, Pages 170-175

  Seok, Heon ^a   Nam, Hyo Jung ^b   Nam, Seung Taek ^b   Kang, Jin Ku ^b   Kim, Sung Kuk ^b   Chang, Jong Soo ^b   Ha, Eun Mi ^c   Park, Young Joo ^d   Kim, Ho ^b  

^a Jungwon University   (South Korea)

^b Daejin University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Antiproliferatory effect; Clostridium difficile toxin a; Extracellular signal related kinases 1 2; Protein protein interaction

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MECHANICS;

BACTERIAL TOXINS; CELL LINE; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN BINDING;

CLOSTRIDIUM DIFFICILE;

EID: 84863251200     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1110.10075     Document Type: Article

References (23)

1. Buzzi, N., A. Colicheo, R. Boland, and A. R. de Boland. 2009. MAP kinases in proliferating human colon cancer Caco-2 cells. Mol. Cell. Biochem. 328: 201-208.
2. Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 49: 83-91.
3. Dumesic, P. A., F. A. Scholl, D. I. Barragan, and P. A. Khavari. 2009. Erk1/2 MAP kinases are required for epidermal G2/M progression. J. Cell Biol. 185: 409-422.
4. Emerson, L. J., M. R. Holt, M. A. Wheeler, M. Wehnert, M. Parsons, and J. A. Ellis. 2009. Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. Biochim. Biophys. Acta 1792: 810-821.
5. He, D., S. J. Hagen, C. Pothoulakis, M. Chen, N. D. Medina, M. Warny, and J. T. LaMont. 2000. Clostridium difficile toxin A causes early damage to mitochondria in cultured cells. Gastroenterology 119: 139-150.
6. He, D., S. Sougioultzis, S. Hagen, J. Liu, S. Keates, A. C. Keates, C. Pothoulakis, and J. T. Lamont. 2002. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122: 1048-1057.
7. Ho, J. G., A. Greco, M. Rupnik, and K. K. Ng. 2005. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 102: 18373-18378.
8. Hofmann, F., C. Busch, and K. Aktories. 1998. Chimeric clostridial cytotoxins: Identification of the N-terminal region involved in protein substrate recognition. Infect. Immun. 66: 1076-1081.
9. Hofmann, F., C. Busch, U. Prepens, I. Just, and K. Aktories. 1997. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272: 11074-11078.
10. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503.
11. Kelly, C. P. and J. T. LaMont. 1998. Clostridium difficile infection. Annu. Rev. Med. 49: 375-390.
12. Kim, H., S. H. Rhee, E. Kokkotou, X. Na, T. Savidge, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J. Biol. Chem. 280: 21237-21245.
13. Kim, H., S. H. Rhee, C. Pothoulakis, and J. T. Lamont. 2009. Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin. Exp. Cell Res. 315: 3336-3344.
14. Lyerly, D. M., K. E. Saum, D. K. MacDonald, and T. D. Wilkins. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47: 349-352.
15. Mazharian, A., S. P. Watson, and S. Severin. 2009. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility and proplatelet formation. Exp. Hematol. 37: 1238-1249.
16. Mitchell, T. J., J. M. Ketley, S. C. Haslam, J. Stephen, D. W. Burdon, D. C. Candy, and R. Daniel. 1986. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 27: 78-85.
17. Na, X., H. Kim, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2008. gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect. Immun. 76: 2862-2871.
18. Na, X., D. Zhao, H. W. Koon, H. Kim, J. Husmark, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology 128: 1002-1011.
19. Reineke, J., S. Tenzer, M. Rupnik, A. Koschinski, O. Hasselmayer, A. Schrattenholz, H. Schild, and C. von Eichel-Streiber. 2007. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446: 415-419.
20. Triadafilopoulos, G., C. Pothoulakis, M. J. O'Brien, and J. T. LaMont. 1987. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93: 273-279.
21. Wang, Z., H. Yang, F. Zhang, Z. Pan, J. Capo-Aponte, and P. S. Reinach. 2009. Suppression of GSK-3 activation prolongs Erk1/ 2 phosphorylation and augments EGF-induced migration in HCEC. Invest. Ophthalmol Vis. Sci. 50.
22. Warny, M., A. C. Keates, S. Keates, I. Castagliuolo, J. K. Zacks, S. Aboudola, et al. 2000. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest. 105: 1147-1156.
23. Zohrabian, V. M., B. Forzani, Z. Chau, R. Murali, and M. Jhanwar-Uniyal. 2009. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res. 29: 119 -123.